Sean Wieland
Stock Analyst at Piper Sandler
(1.36)
# 3,486
Out of 4,944 analysts
31
Total ratings
40.91%
Success rate
-0.63%
Average return
Main Sectors:
Stocks Rated by Sean Wieland
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| OMCL Omnicell | Maintains: Overweight | $57 → $55 | $31.35 | +75.44% | 12 | Aug 11, 2025 | |
| PRVA Privia Health Group | Maintains: Overweight | $35 → $36 | $21.02 | +71.27% | 3 | Aug 11, 2025 | |
| AMWL American Well | Maintains: Overweight | $100 → $120 | $7.19 | +1,568.98% | 2 | Jun 23, 2022 | |
| HIMS Hims & Hers Health | Maintains: Overweight | $8 → $6 | $48.33 | -87.59% | 3 | May 26, 2022 | |
| DOCS Doximity | Maintains: Overweight | $81 → $44 | $64.02 | -31.27% | 2 | May 19, 2022 | |
| IQV IQVIA Holdings | Maintains: Neutral | $261 → $231 | $190.23 | +21.43% | 4 | Feb 18, 2022 | |
| TDOC Teladoc Health | Maintains: Overweight | $305 → $291 | $7.44 | +3,811.29% | 5 | Feb 25, 2021 |
Omnicell
Aug 11, 2025
Maintains: Overweight
Price Target: $57 → $55
Current: $31.35
Upside: +75.44%
Privia Health Group
Aug 11, 2025
Maintains: Overweight
Price Target: $35 → $36
Current: $21.02
Upside: +71.27%
American Well
Jun 23, 2022
Maintains: Overweight
Price Target: $100 → $120
Current: $7.19
Upside: +1,568.98%
Hims & Hers Health
May 26, 2022
Maintains: Overweight
Price Target: $8 → $6
Current: $48.33
Upside: -87.59%
Doximity
May 19, 2022
Maintains: Overweight
Price Target: $81 → $44
Current: $64.02
Upside: -31.27%
IQVIA Holdings
Feb 18, 2022
Maintains: Neutral
Price Target: $261 → $231
Current: $190.23
Upside: +21.43%
Teladoc Health
Feb 25, 2021
Maintains: Overweight
Price Target: $305 → $291
Current: $7.44
Upside: +3,811.29%